Tolmar Inc.   Report issue

For profit Phase 1 Phase 3
Founded: Fort Collins CO United States (2006)
Status: No NME R&D (2006)

Organization Overview

First Clinical Trial
2015
NCT02452931
First Marketed Drug
2006
doxycycline (vibramycin)
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

TOLMAR | Tolmar Inc. | TOLMAR THERAP